» Articles » PMID: 17785203

Ultraconserved Regions Encoding NcRNAs Are Altered in Human Leukemias and Carcinomas

Abstract

Noncoding RNA (ncRNA) transcripts are thought to be involved in human tumorigenesis. We report that a large fraction of genomic ultraconserved regions (UCRs) encode a particular set of ncRNAs whose expression is altered in human cancers. Genome-wide profiling revealed that UCRs have distinct signatures in human leukemias and carcinomas. UCRs are frequently located at fragile sites and genomic regions involved in cancers. We identified certain UCRs whose expression may be regulated by microRNAs abnormally expressed in human chronic lymphocytic leukemia, and we proved that the inhibition of an overexpressed UCR induces apoptosis in colon cancer cells. Our findings argue that ncRNAs and interaction between noncoding genes are involved in tumorigenesis to a greater extent than previously thought.

Citing Articles

New Challenges in Bladder Cancer Diagnosis: How Biosensing Tools Can Lead to Population Screening Opportunities.

Tortora F, Guastaferro A, Barbato S, Febbraio F, Cimmino A Sensors (Basel). 2025; 24(24.

PMID: 39771612 PMC: 11679013. DOI: 10.3390/s24247873.


A first comprehensive analysis of Transcribed Ultra Conserved Regions uncovers important regulatory functions of novel non-coding transcripts in gliomas.

Gibert Jr M, Zhang Y, Saha S, Marcinkiewicz P, Dube C, Hudson K Res Sq. 2024; .

PMID: 38699302 PMC: 11065071. DOI: 10.21203/rs.3.rs-4164642/v1.


AMPFLDAP: Adaptive Message Passing and Feature Fusion on Heterogeneous Network for LncRNA-Disease Associations Prediction.

Su Y, Liu J, Wu Q, Gao Z, Wang J, Li H Interdiscip Sci. 2024; 16(3):608-622.

PMID: 38581626 DOI: 10.1007/s12539-024-00610-5.


Non-Coding RNAs as Key Regulators in Lung Cancer.

Gilyazova I, Gimalova G, Nizamova A, Galimova E, Ishbulatova E, Pavlov V Int J Mol Sci. 2024; 25(1).

PMID: 38203731 PMC: 10778604. DOI: 10.3390/ijms25010560.


The expression and function of long noncoding RNAs in hepatocellular carcinoma.

Du J, Su Y, Gao J, Tai Y Cancer Innov. 2023; 2(6):488-499.

PMID: 38125766 PMC: 10730004. DOI: 10.1002/cai2.90.